Open AccessMetastatic adamantinoma responds to treatment with receptor tyrosine kinase and Aurora A kinase inhibitor
Author(s) -
Imran Unal,
Odile David,
Arkadiusz Z. Dudek
Publication year - 2015
Publication title -
journal of solid tumors
Language(s) - English
Resource type - Journals
eISSN - 1925-4075
pISSN - 1925-4067
DOI - 10.5430/jst.v5n2p27
Subject(s) - pazopanib , medicine , adamantinoma , cancer research , radiation therapy , tyrosine kinase inhibitor , tyrosine kinase , targeted therapy , oncology , receptor , cancer , sunitinib , ameloblastoma , anatomy , maxilla
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom